MODULATION OF HORMONE RESPONSIVE SYSTEMS BY RAS ONCOGENE PRODUCT

RAS 癌基因产物对激素反应系统的调节

基本信息

项目摘要

The goal of our research is to understand the modulation of signal transduction mechanisms during the expression of a well-defined oncogene. We had previously found that ras transformation of MDCK cells caused a selective loss of glucagon receptors and this loss can be restored by treatment of cells with PGE2. The effect of PGE2 seems to be mediated by cyclic AMP. We have now found that, subsequent to the elevation of cyclic AMP, but preceding the appearance of glucagon sensitivity, PGE2 decreased the level of inositol 1,4,5-triphosphate in the transformed MDCK cells. Both effects of PGE2 on IP3 and on the induction of hormone sensitivity were blocked by phorbol ester. We conclude that the perturbation of the IP3 pathway by cyclic AMP is likely to be causally related to the induction of glucagon response. In order to examine the causal relationship between the expression of ras gene and the various changes of signal transduction more closely, we have transfected cells with plasmid containing inducible ras oncogenes to allow more precise control of p2l production. Using transfected 3T3 cells (obtained from others) and MDCK cells, we found that cyclic AMP-mediated hormone sensitivity is unaltered even when ras is fully expressed. In contrast, EGF receptors are rapidly desensitized, due to a loss of high affinity sites, when ras is expressed. Since diacylglycerol is also elevated when p2l is induced by dexamethasone, the desensitization of EGF receptors is likely caused by an activation of protein kinase. We are now screening the transfected GH3 cell line, which possesses high density EGF receptors, for clones expressing inducible ras, so that we can study the mechanism responsible for the desensitization of EGF receptors by protein kinase C. We have found a rapid increase in transfected 3T3 cells and a rapid decrease of PGE2 production in transfected MDCK cells, upon the expression of ras gene. This is consistent with previous findings using virally transformed cells.
The goal of our research is to understand the modulation of signal transduction mechanisms during the expression of a well-defined oncogene. We had previously found that ras transformation of MDCK cells caused a selective loss of glucagon receptors and this loss can be restored by treatment of cells with PGE2. The effect of PGE2 seems to be mediated by cyclic AMP. We have now found that, subsequent to the elevation of cyclic AMP, but preceding the appearance of glucagon sensitivity, PGE2 decreased the level of inositol 1,4,5-triphosphate in the transformed MDCK cells. Both effects of PGE2 on IP3 and on the induction of hormone sensitivity were blocked by phorbol ester. We conclude that the perturbation of the IP3 pathway by cyclic AMP is likely to be causally related to the induction of glucagon response. In order to examine the causal relationship between the expression of ras gene and the various changes of signal transduction more closely, we have transfected cells with plasmid containing inducible ras oncogenes to allow more precise control of p2l 生产。 Using transfected 3T3 cells (obtained from others) and MDCK cells, we found that cyclic AMP-mediated hormone sensitivity is unaltered even when ras is fully expressed. In contrast, EGF receptors are rapidly desensitized, due to a loss of high affinity sites, when ras is expressed. Since diacylglycerol is also elevated when p2l is induced by dexamethasone, the desensitization of EGF receptors is likely caused by an activation of protein kinase. We are now screening the transfected GH3 cell line, which possesses high density EGF receptors, for clones expressing inducible ras, so that we can study the mechanism responsible 为了通过蛋白激酶对EGF受体脱敏。我们有 发现转染的3T3细胞迅速增加,并迅速减少 转染的MDCK细胞中的PGE2产生,在RA的表达后 基因。这与先前的发现使用病毒转化是一致的 细胞。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

M C LIN其他文献

M C LIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('M C LIN', 18)}}的其他基金

REGULATION OF HORMONE RESPONSIVENESS DURING CELLULAR DIFFERENTIATION
细胞分化过程中激素反应的调节
  • 批准号:
    4689014
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REGULATION OF HORMONE RESPONSIVENESS DURING CELLULAR DIFFERENTIATION
细胞分化过程中激素反应的调节
  • 批准号:
    3940229
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MODULATION OF HORMONE RESPONSIVE SYSTEMS BY RAS ONCOGENE PRODUCT
RAS 癌基因产物对激素反应系统的调节
  • 批准号:
    3917358
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REGULATION OF HORMONE RESPONSIVENESS DURING CELLULAR DIFFERENTIATION
细胞分化过程中激素反应的调节
  • 批准号:
    3964008
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似国自然基金

MDS克隆细胞中TWIST1影响BMMSC成脂/成骨分化重编程的机制研究
  • 批准号:
    82370147
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
骨髓微环境对造血干细胞异常克隆演化的作用及调控机制
  • 批准号:
    82370117
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
基于单细胞多组学数据解析影响肿瘤亚克隆谱系分化的调控元件
  • 批准号:
    32300543
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
H4K20me3导致猪克隆胚细胞周期和卵裂异常的机制研究
  • 批准号:
    32372883
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
骨肉瘤干细胞样亚克隆诱导CD36+肌成纤维细胞促进免疫逃逸的机制研究
  • 批准号:
    82373377
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目

相似海外基金

Modulating prostaglandin E2 receptor activity to improve pancreatic islet function
调节前列腺素 E2 受体活性以改善胰岛功能
  • 批准号:
    10360796
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Modulating prostaglandin E2 receptor activity to improve pancreatic islet function
调节前列腺素 E2 受体活性以改善胰岛功能
  • 批准号:
    10611349
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Mechanisms of TOR-dependent control of autophagy in Drosophila
果蝇 TOR 依赖性自噬控制机制
  • 批准号:
    10459598
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Mechanisms of TOR-dependent control of autophagy in Drosophila
果蝇 TOR 依赖性自噬控制机制
  • 批准号:
    10297218
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Mechanisms of TOR-dependent control of autophagy in Drosophila
果蝇 TOR 依赖性自噬控制机制
  • 批准号:
    10625514
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了